Induction of IL-1Ra in Resistant and Responsive Hepatitis C Patients Following Treatment with IFN-con1
Authors:
- 1 May 2002
- journal article
- research article
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 22 (5) , 549-554
Abstract
Hepatitis C virus (HCV) infection is resistant to interferon-α (IFN-α) in some patients. The mechanism of this resistance is unknown. Interleukin-1 receptor antagonist (IL-1Ra) is induced by IFN-α and is a good indicator of IFN activity. In the current study, we compared IL-1Ra levels in rapid virologic responders and flat responders who showed resistance to IFN. Three groups of patients were examined, including those who received a single dose of consensus IFN (IFN-con1), patients who received daily IFN-con1 for 1 week, and patients who received IFN-con1 daily for 24 weeks. Serum IL-1Ra, IL-6, and HCV RNA were measured serially in all groups. Serum IL-1Ra levels increased rapidly in all patients with hepatitis C after IFN-α administration, irrespective of their virologic response. IL-1Ra levels remained elevated at 1 week but were similar to baseline by week 2 of treatment in patients receiving continuous therapy. IL-6 levels also increased acutely but rose more slowly than IL-1Ra levels. The increase in IL-1Ra and IL-6 observed in both flat and rapid virologic responders indicates that IFN receptors are functioning in patients with IFN-resistant hepatitis C and that the lack of response is related to other virologic or immunologic factors.Keywords
This publication has 16 references indexed in Scilit:
- An Analysis of Acute Changes in Interleukin-6 Levels After Treatment of Hepatitis C with Consensus InterferonJournal of Interferon & Cytokine Research, 2001
- Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytesAntiviral Research, 2000
- HEPATITIS C VIRAL DYNAMICSClinics in Liver Disease, 1999
- Comparison of cytotoxic T-lymphocyte responses to hepatitis C virus core protein in uninfected and infected individualsJournal of Medical Virology, 1999
- Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): a depot IL-1raEuropean Journal of Immunology, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis CHepatology, 1998
- Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis CHepatology, 1997
- Type 1 Interferon as an Antiinflammatory Agent: Inhibition of Lipopolysaccharide-Induced Interleukin-lβ and Induction of Interleukin-1 Receptor AntagonistJournal of Interferon & Cytokine Research, 1995
- Immuno-modulating properties of interferonsPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1982